THR-18

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTHR-18
Drug Alias NamePlasminogen activator inhibitor-1-derived 18-mer peptideTHR-18
ClassificationBiologics
Mechanisms of ActionPlasminogen activator inhibitor 1 modulators
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineIsraelMoldova, Republic of
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHadassah Medical OrganizationD-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD-Pharm LtdThrombotech Ltd
Active IndicationsN/A
Inactive IndicationsIschemic StrokeStroke

Other Information

ATC CodeN/A
Related LinksN/A